CALDERONE, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 14.923
EU - Europa 7.029
AS - Asia 2.206
AF - Africa 271
SA - Sud America 29
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.490
Nazione #
US - Stati Uniti d'America 14.510
IT - Italia 2.846
SE - Svezia 1.287
CN - Cina 1.129
DE - Germania 742
BG - Bulgaria 714
CA - Canada 409
VN - Vietnam 376
GB - Regno Unito 309
TR - Turchia 282
UA - Ucraina 229
FI - Finlandia 215
SG - Singapore 185
CI - Costa d'Avorio 184
AT - Austria 169
FR - Francia 138
HK - Hong Kong 92
RU - Federazione Russa 87
PL - Polonia 77
CH - Svizzera 71
IN - India 70
SN - Senegal 54
BE - Belgio 46
NL - Olanda 22
AU - Australia 21
NG - Nigeria 21
GR - Grecia 19
KR - Corea 14
BR - Brasile 12
CL - Cile 11
HU - Ungheria 10
IR - Iran 9
JP - Giappone 9
PK - Pakistan 8
ES - Italia 7
IE - Irlanda 6
EU - Europa 5
HR - Croazia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
DK - Danimarca 4
MX - Messico 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
RS - Serbia 3
ZA - Sudafrica 3
AR - Argentina 2
AZ - Azerbaigian 2
EE - Estonia 2
MA - Marocco 2
NO - Norvegia 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
A1 - Anonimo 1
AM - Armenia 1
BD - Bangladesh 1
BY - Bielorussia 1
CY - Cipro 1
ET - Etiopia 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
UG - Uganda 1
UY - Uruguay 1
Totale 24.490
Città #
Woodbridge 2.130
Ann Arbor 1.651
Fairfield 1.557
Houston 1.363
Chandler 1.240
Ashburn 886
Serra 725
Sofia 714
Milan 669
Seattle 637
Wilmington 572
Cambridge 530
Beijing 452
New York 432
Ottawa 385
Princeton 313
Jacksonville 298
Lawrence 285
Izmir 263
Medford 235
Nanjing 203
Dong Ket 186
Abidjan 184
Des Moines 167
Vienna 165
Frankfurt am Main 118
London 109
Dearborn 107
San Diego 89
Pisa 88
Hong Kong 84
Nanchang 84
Florence 83
Rome 80
Boulder 77
Warsaw 71
Redwood City 67
Bern 62
Dakar 54
Los Angeles 54
Marseille 54
Jüchen 50
Washington 45
Brussels 44
Shenyang 43
Grafing 41
Kunming 39
Hebei 37
Boardman 34
Falls Church 33
Ogden 33
Changsha 32
Norwalk 32
Pune 31
Tianjin 30
Bremen 29
Auburn Hills 26
Jiaxing 26
Nürnberg 26
Hangzhou 23
Lagos 21
Livorno 21
Guangzhou 20
Lancaster 19
Hefei 18
San Francisco 16
Shanghai 16
Orange 15
Jinan 14
Chicago 13
Napoli 13
Vicopisano 12
Carrara 10
Redmond 10
Amsterdam 9
Detroit 9
Helsinki 9
Lucca 9
Toronto 9
Dallas 8
Indiana 8
Scafati 8
Incisa 7
Islamabad 7
Kocaeli 7
Lanzhou 7
Pessac 7
Phoenix 7
Pieve 7
Pontedera 7
San Mateo 7
Siena 7
Wuhan 7
Alessandria 6
Bologna 6
Canberra 6
Capannori 6
Changchun 6
Columbus 6
Düsseldorf 6
Totale 18.583
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 262
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 216
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 209
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 175
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 173
Antioxidant, cardiomyocyte anti-ageing properties and phytochemical profile of Citrus bergamia juices 173
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 171
An update on hybrid drugs in cardiovascular drug research 168
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 168
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 163
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 162
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 161
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 160
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 158
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 157
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 154
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 154
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 151
Antioxidant and Antisenescence Effects of Bergamot Juice 150
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 150
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 149
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 148
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 145
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 142
An alternative method to evaluate the nature of an antagonist and its potency. A theoretical approach 141
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 140
Memantine prodrug as a new agent for alzheimer’s disease 140
A modified aortic multiple-ring preparation for functional studies 139
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 139
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 138
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 136
Synthesis of 1,8 - naphthyridine derivatives: potential antihypertensive agents. Part VII 135
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 134
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 133
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 131
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 131
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 131
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 130
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 129
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 129
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 128
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 128
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 127
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 126
Synthesis of 1,8-naphthyridine derivatives: potential antihypertensive agents. Part VIII 126
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 126
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method 123
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 123
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 123
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 123
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 123
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 122
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 121
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 121
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 120
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 119
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 119
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 118
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 117
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 116
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 116
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 115
Intrinsic activity and EC50: the simplest tools for the evaluation of the dissociation constant of a partial agonist 114
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 114
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 113
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 113
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 112
Vasodilator activity of crude methanolic extract of Gentiana Kokiana Perr Et Song (Gentianaceae) 111
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 110
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 109
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 109
Evaluation of the NO-releasing properties of NO-donor linkers 109
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 109
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 108
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 106
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 106
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 106
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 104
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 104
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 104
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 103
Editorial for the special issue on "Drugs targeting potassium channels" 102
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 102
Pharmacological action of aqueous crude extracts of Artemisia verlotorum Lamotte (Compositae) 102
Prediction of hERG Potassium Channel Affinity by the CODESSA Approach 102
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 102
New amido derivatives as potential BKCa potassium channel activators. XI 102
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 102
VASORELAXANT EFFECTS OF THE CHLOROFORMIC CRUDE EXTRACT OF BUPLEURUM FRUTICOSUM L. (UMBELLIFERAE) ROOTS ON RAT THORACIC AORTA 101
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 101
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 100
Synthesis and b-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]-pyridine: potential antihypertensive agents. Part IX 100
null 100
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 100
QT PROLONGATION IN ANAESTHETIZED GUINEA-PIGS: AN EXPERIMENTAL APPROACH FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG CANDIDATES 99
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 99
APRIKALIM ABOLISHES THE QT INTERVAL PROLONGATION THIORIDAZINE-INDUCED BY THE ACTIVATION OF SARCOPLASMIC KATP CHANNELS 98
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 98
null 98
Antiviral properties of an aqueous extract of a green algae Caulerpa taxifolia (Vahl) C. Agardh. 96
Totale 12.823
Categoria #
all - tutte 63.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019932 0 0 0 0 0 0 0 0 0 0 522 410
2019/20204.487 548 331 407 303 386 483 526 343 435 284 335 106
2020/20212.422 176 122 127 109 232 196 130 222 318 202 150 438
2021/20223.287 63 220 98 159 537 536 107 172 130 108 252 905
2022/20234.211 523 540 277 346 465 575 41 272 808 24 212 128
2023/20242.826 333 406 374 190 467 626 149 95 59 89 38 0
Totale 25.224